• Намалена цена

2022 Nelson`s Pediatric Antimicrobial Therapy 28th ed

Референция: 9781610025645

100,00 лв.
90,00 лв. Спестявате 10%
С вкл. данък
Количество
Последна наличност

Cash On Delivery Payment is available

AAP Снабдител
AAP
  • Security policy (edit with Customer reassurance module) Security policy (edit with Customer reassurance module)
  • Delivery policy (edit with Customer reassurance module) Delivery policy (edit with Customer reassurance module)
  • Return policy (edit with Customer reassurance module) Return policy (edit with Customer reassurance module)

Completely updated and revised, the 28th edition of this

best-selling reference provides instant access to the latest

recommendations for treatment of infectious diseases in children.

 

For

each disease, the authors provide a commentary to help select the best

of all antimicrobial choices. Drug descriptions cover all antimicrobial

agents available today and include complete information about dosing

regimens.

 

TOPICS INCLUDE

Antimicrobial Therapy by Clinical Syndromes

Antimicrobial Therapy for Neonates

Choosing Among

Antibiotics

Antifungal Agents

Antiviral Agents

Antiparasitic Agents

Oral Step-down Therapy for Serious Infections

Prevention of Symptomatic Infection

Approach to Antibiotic Allergies

Antibiotic Stewardship

New in the 28th Edition

Updated

recommendations on acute hematogenous osteomyelitis, based on newly

published guidelines by the Pediatric Infectious Diseases Society and

the Infectious Diseases Society of America, including information on a

decrease in the incidence of MRSA infections, allowing the

recommendation of cefazolin, again, in empiric therapy for most

pediatric bone infections

Updated recommendations on influenza treatment and prophylaxis, reflecting American Academy of Pediatrics guidance for 2021–2022

Ceftazidime/avibactam

now preferred over fluoroquinolones for treatment of Klebsiella

pneumoniae carbapenemase–producing enteric bacilli, if susceptible

Cefiderocol,

a new iron-binding siderophore cephalosporin class, recently approved

in adults for treatment of many drug-resistant pathogens, particularly

Acinetobacter, Stenotrophomonas, and Pseudomonas; under study in

children

New dosing for posaconazole suspension formulation

New approaches to mucormycosis

Added baloxavir for children 12+ years old

Online updates of COVID-19 therapies once emergency use authorization

9781610025645

Техническо описание

Корица на нига
Твърд
Размер
111 X 187 mm
Издание
Чужд Език(Английски)

16 other products in the same category: